Moreover, the presence of SSTR subtype 1 has also been proposed to have a better therapeutic response in MTC [447]; however, SSTR1 is well expressed in most thyroid cancers in comparison to SSTR2. This evidence concerns the gene SSTR2 and medullary thyroid gland carcinoma.